Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Long-Term Debt / Capital

Arbutus Biopharma Cp Long-Term Debt / Capital Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Long-Term Debt / Capital from 2016 to 2017.
  • Arbutus Biopharma Cp Long-Term Debt / Capital for the quarter ending December 12, 2017 was $6m a 3.27% increase of 0m year over year
  • Arbutus Biopharma Cp Long-Term Debt / Capital for the last 12 months ending December 12, 2017 was $6m a 3.27% increase of 0m year over year
  • Arbutus Biopharma Cp Annual Long-Term Debt / Capital for 2017 was $6m a 9.53% increase of 1m from 2016
  • Arbutus Biopharma Cp Annual Long-Term Debt / Capital for 2016 was $6m
Other Ratios Metrics:
  • Arbutus Biopharma Cp Total Debt / Capital for the quarter ending December 12, 2017 was $6m a 3.27% increase of 0m year over year
  • Arbutus Biopharma Cp Other Liabilities for the quarter ending December 12, 2018 was $17m a -61.02% decrease of -10m year over year
  • Arbutus Biopharma Cp Total Debt / Equity for the quarter ending December 12, 2017 was $7m a 3.48% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Long-Term Debt / Capital Data

12/2017$6m
09/2017$7m
06/2017$6m
03/2017$6m
12/2016$6m

Annual ABUS Long-Term Debt / Capital Data

2017$6m
2016$6m